RxDoctor Payments Data

Paul Evans, PA

Surgical · Falmouth, MENPI 1477549012

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (56.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 94.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $12,056 and has fallen 69.0% since, to $3,732 in 2025. Among surgical clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,962in general payments, 2019–2025

Across 63 payments — averaging $332.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$20K
  • Zimmer Biomet$674
  • Medical Device Business Services, Inc.$411
  • Johnson & Johnson$118
  • Stryker$58

What the payments were for

  • Speaking & faculty fees$11,88557%
  • Travel & lodging$5,00324%
  • Food & beverage$3,66317%
  • Education$4112%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,962 in reported general payments places this provider in the 95th percentile of 105 surgical providers in Maine.

See all surgical providers in Maine

Medicare billing

Part B allowed, 2024
$18,710
Medicare patients
145
Services billed
208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib38$453
Oxycodone Hcl41$271
Amoxicillin77$130
Cephalexin31$68
Pregabalin20$45
Clindamycin Hcl12$39

Paid to pharmacies, not to this prescriber.

Other surgical in Falmouth

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →